Skip to main content
. 2020 Nov 10;11(45):4195–4200. doi: 10.18632/oncotarget.27793

Figure 1.

Figure 1

(A) The clinical timeline of the 55-year-old male diagnosed with distal CBD type of periampullary carcinoma. (B) Transverse sections of representative PET-CT scan images before treatment (Baseline) and after start of Cyclophosphamide + Methotrexate + Trastuzumab regimen depicted complete response.